Cannabis Science logo.png
Mr. Raymond C. Dabney Prepares Cannabis Science for the Next Level With Key Acquisitions Negotiated and Planned Mergers, a New Branding Splash, and a Black-Tie Dinner Awards Gala for the Ages
July 08, 2019 07:34 ET | Cannabis Science, Inc.
Acquisitions Designed to Complete the Company’s Financials, Introduce New Branding, and Hold Its 2019 CBIS Awards Gala to Thank the Company’s Shareholders and Stakeholders  IRVINE, CA, July 08,...
CBIS Black Tie Gala
Cannabis Science Receives Tremendous Response for CEO’s Personal Shareholder Loyalty Gift; Planning Underway for the Company’s 2019 Black-Tie Dinner Awards Gala Presentations
February 08, 2019 08:09 ET | Cannabis Science, Inc.
IRVINE, CA, Feb. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it...
CBIS
Cannabis Science Receives Overwhelming Response From Mr. Raymond C. Dabney’s Shareholder Loyalty Gift Package; Get Set for Cannabis Science 2019 Black-Tie Dinner Awards Gala
January 14, 2019 11:26 ET | Cannabis Science, Inc.
IRVINE, CA, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces it is...
CBIS
The Cannabis Science Inaugural Black-Tie Dinner Awards Gala Final Planning Underway; Recognizing Major Industry Accomplishments, Killing Cancer, and Awarding Unprecedented Shareholder Loyalty
November 21, 2018 08:28 ET | Cannabis Science, Inc.
IRVINE, CA, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
RCD
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply
April 10, 2018 07:51 ET | Cannabis Science, Inc.
IRVINE, CA, April 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to issue a 2018 First...